SHIRLEY, NY, March 13, 2026 /24-7PressRelease/ -- Creative Biolabs, a global pioneer in lipid-based delivery technologies, is proud to announce the expansion of its specialized formulation services, focusing on three next-generation vesicular systems: Ethosomes, Transfersomes, and Transethosomes. These platforms are specifically engineered to overcome the natural barrier of the stratum corneum, offering high efficiency in both topical and systemic drug delivery.

As the pharmaceutical and cosmetic industries shift toward non-invasive delivery methods, the primary challenge remains ensuring that therapeutic agents can penetrate the skin's dense lipid bilayer. Creative Biolabs' latest suite of services addresses these hurdles by leveraging the unique "deformable" and "permeation-enhancing" properties of advanced lipid vesicles.

Innovative Solutions for Complex Delivery
The company's development platforms cover three distinct technologies:
• Ethosomes: Utilizing high concentrations of ethanol to fluidize skin lipids, Ethosomes enable deep-skin penetration for both hydrophilic and lipophilic drugs.
• Transfersomes: These "ultra-deformable" vesicles incorporate edge activators, allowing them to squeeze through tiny skin pores to deliver high-molecular-weight molecules like proteins and peptides.
• Transethosomes: A hybrid system combining the benefits of both ethanol and surfactants, offering the highest skin flux and superior stability for complex dermatological applications.
Voices of Innovation: Customer Success Stories

The impact of these platforms is best reflected in the feedback from the global research community.

"We had struggled for months to stabilize a sensitive peptide for topical application," shared a Senior Scientist from a leading European biotech firm. "Creative Biolabs' Transfersome platform was a game-changer. Their team didn't just provide a carrier; they optimized the entire formulation to ensure our molecule remained bioactive while achieving systemic absorption levels we previously thought impossible without injections."

Another researcher from a specialized dermatology lab noted the efficiency of the Ethosome platform: "The penetration data we received was remarkable. By using Creative Biolabs' Ethosome development service, we saw a 40% increase in the localized delivery of our anti-inflammatory lead compound compared to traditional liposomes. Their technical support and characterization reports were incredibly detailed, making our transition to in vivo trials seamless."

A Commitment to Scientific Excellence
"Our goal is to provide a 'one-stop-shop' for lipid-based delivery challenges" said a spokesperson for Creative Biolabs. "We understand that every molecule is unique. Whether it's enhancing the solubility of a drug or ensuring it reaches a specific layer of the dermis, our platforms are designed to be flexible and highly effective."

Creative Biolabs offers a comprehensive service range, including vesicle size optimization, entrapment efficiency analysis, and in vitro skin permeation studies (IVPT). This data-driven approach ensures that every client receives a formulation optimized for their specific clinical goals.

Learn more, please visit https://www.creative-biolabs.com/lipid-based-delivery/.

About Creative Biolabs
Creative Biolabs is a leading biotechnology company with extensive experience in lipid-based drug delivery systems. With world-class scientists and state-of-the-art facilities, the company provides innovative solutions for the pharmaceutical and cosmetic industries, specializing in the development of liposomes, niosomes, and advanced elastic vesicles.

This contant was orignally distributed by 24-7 Press Release. Blockchain Registration, Verification & Enhancement provided by NewsRamp™. The source URL for this press release is Creative Biolabs Announces Cutting-Edge Lipid-Based Platforms to Revolutionize Transdermal Drug Delivery.